Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) have earned a consensus rating of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating and four have issued a buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $27.25.

GRDN has been the subject of several research analyst reports. Wall Street Zen cut shares of Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Friday, October 3rd. Truist Financial upped their price objective on shares of Guardian Pharmacy Services from $28.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, September 26th. Oppenheimer started coverage on Guardian Pharmacy Services in a research report on Friday, October 10th. They set an “outperform” rating and a $30.00 target price on the stock. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Guardian Pharmacy Services in a report on Wednesday, October 8th.

Guardian Pharmacy Services Stock Down 0.2%

GRDN stock opened at $24.36 on Friday. The business has a 50 day moving average price of $25.62 and a 200 day moving average price of $23.21. The stock has a market cap of $1.54 billion and a price-to-earnings ratio of -16.03. Guardian Pharmacy Services has a fifty-two week low of $16.91 and a fifty-two week high of $30.39.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of institutional investors have recently modified their holdings of the business. Brown Advisory Inc. boosted its stake in Guardian Pharmacy Services by 5.0% during the 2nd quarter. Brown Advisory Inc. now owns 1,682,476 shares of the company’s stock worth $35,854,000 after purchasing an additional 79,652 shares during the period. Franklin Resources Inc. boosted its stake in shares of Guardian Pharmacy Services by 32.2% during the second quarter. Franklin Resources Inc. now owns 976,207 shares of the company’s stock worth $20,803,000 after buying an additional 237,630 shares during the period. TimesSquare Capital Management LLC purchased a new position in shares of Guardian Pharmacy Services during the second quarter worth about $17,351,000. Wellington Management Group LLP grew its holdings in shares of Guardian Pharmacy Services by 14.2% during the first quarter. Wellington Management Group LLP now owns 464,924 shares of the company’s stock worth $9,884,000 after buying an additional 57,924 shares during the last quarter. Finally, Woodline Partners LP increased its position in Guardian Pharmacy Services by 1.5% in the 1st quarter. Woodline Partners LP now owns 421,203 shares of the company’s stock valued at $8,955,000 after acquiring an additional 6,083 shares during the period.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.